|
⚲
|
| Keyboard |
| Santos da Silva Jorge
✚
|
|
|---|---|
| CIK # | 0001920509 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001920509] | |
| 4 | [0001920509] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Santos da Silva Jorge | |
| MoonLake Immunotherapeutics |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MoonLake Immunotherapeutics MLTX
Stock Option (Right to Buy) · derivative
|
2026-01-07 | Grant | 520,342 | $0.00 | |
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2025-12-19 | Conversion | 5,836 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-19 | Conversion | 196,316 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2025-12-19 | Disposed to issuer | 196,316 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-09 | Sell | 70,000 | $14.49 | 1,014,300 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-08 | Sell | 130,000 | $15.08 | 1,960,400 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-02-27 | Grant | 95,763 | $0.00 | |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-29 | Sell | 4,740 | $55.89 | 264,919 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-28 | Sell | 56,065 | $55.00 | 3,083,575 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-27 | Sell | 62,810 | $55.00 | 3,454,550 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-21 | Sell | 1,125 | $55.27 | 62,179 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-20 | Sell | 20,000 | $57.44 | 1,148,800 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-16 | Sell | 20,000 | $60.15 | 1,203,000 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2024-02-15 | Sell | 20,000 | $60.18 | 1,203,600 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2023-10-01 | Conversion | 140,071 | ||
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2023-10-01 | Conversion | 4,164 | ||
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2023-10-01 | Conversion | 90,000 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2023-10-01 | Disposed to issuer | 140,071 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2023-10-01 | Conversion | 3,027,483 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2023-10-01 | Disposed to issuer | 3,027,483 |